AZITHROMYCIN DECREASES EXACERBATIONS IN NON-CYSTIC FIBROSIS BRONCHIECTASIS

被引：0
|
作者：
Jayaram, L. [1 ]
Wong, C. A. [2 ]
Karalus, N. [3 ]
Eaton, T.
Tong, C. [4 ]
Hockey, H. [5 ]
Milne, D. [6 ]
Ferguson, W. [6 ]
Tuffery, C. [3 ]
Sexton, P. [6 ]
Storey, L. [2 ]
Ashton, T. [7 ]
机构：
[1] Monash Med Ctr, Melbourne, Vic, Australia
[2] CMDHB, Auckland, NZ, New Zealand
[3] WDHB, Hamilton, New Zealand
[4] CCRep, Auckland, NZ, New Zealand
[5] Biometr Matters Ltd, Hamilton, New Zealand
[6] ADHB, Auckland, NZ, New Zealand
[7] Sch Populat Hlth, Auckland, NZ, New Zealand
来源：
RESPIROLOGY | 2012年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [31] Nontuberculous Mycobacteria in Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis
    Park, In Kwon
    Olivier, Kenneth N.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 36 (02) : 217 - 224
  • [32] Using Cystic Fibrosis Therapies for Non-Cystic Fibrosis Bronchiectasis
    ElMaraachli, Wael
    Conrad, Douglas J.
    Wang, Angela C. C.
    CLINICS IN CHEST MEDICINE, 2016, 37 (01) : 139 - +
  • [33] Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non-Cystic Fibrosis Bronchiectasis The BAT Randomized Controlled Trial
    Altenburg, Josje
    de Graaff, Casper S.
    Stienstra, Ymkje
    Sloos, Jacobus H.
    van Haren, Eric H. J.
    Koppers, Ralph J. H.
    van der Werf, Tjip S.
    Boersma, Wim G.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (12): : 1251 - 1259
  • [34] Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial
    Wong, Conroy
    Jayaram, Lata
    Karalus, Noel
    Eaton, Tam
    Tong, Cecilia
    Hockey, Hans
    Milne, David
    Fergusson, Wendy
    Tuffery, Christine
    Sexton, Paul
    Storey, Louanne
    Ashton, Toni
    LANCET, 2012, 380 (9842): : 660 - 667
  • [35] PREVENTION OF EXACERBATION OF NON-CYSTIC FIBROSIS BRONCHIECTASIS WITH COMBINATION OF AZTREONAM LYSINE INHALATION AND AZITHROMYCIN
    Kundu, Sucheta
    Adyanthaya, Sindhoora
    Bajwa, Manjyot
    Stevasarova, Aksiniya
    Westerman, Jan
    CHEST, 2021, 160 (04) : 1767A - 1767A
  • [36] Risk factors for influenza-induced exacerbations and mortality in non-cystic fibrosis bronchiectasis
    Huang, Hung Yu
    Ko, Po-Chuan
    Wang, Chun-Hua
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [37] Factors associated with recurrence of severe exacerbations in Non-cystic fibrosis bronchiectasis in developping countries
    Bachouch, Imen
    Belloumi, Nidhal
    Slim, Azza
    Jrad, Sonia
    Taboubi, Amir
    Chermiti, Fatma
    Fenniche, Soraya
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [38] Risk Factors for Influenza-Induced Exacerbations and Mortality in Non-Cystic Fibrosis Bronchiectasis
    Huang, Hung-Yu
    Lo, Chun-Yu
    Chung, Fu-Tsai
    Huang, Yu-Tung
    Ko, Po-Chuan
    Lin, Chang-Wei
    Huang, Yu-Chen
    Chung, Kian Fan
    Wang, Chun-Hua
    VIRUSES-BASEL, 2023, 15 (02):
  • [39] BRIDGING THE GAP: A NOVEL SYMPTOM DIARY FOR NON-CYSTIC FIBROSIS BRONCHIECTASIS (NCFB) EXACERBATIONS
    Shih, V.
    Jison, M.
    Bark, E.
    Chalmers, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S31 - S31
  • [40] Azithromycin for the treatment of non-cystic fibrosis bronchiecstasis
    Attwood, Claire
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2012, 6 (05) : 478 - 478
12345